bimolane has been researched along with Sarcoma 180 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finch, M; Hellmann, K; Hutchinson, GE; Li, XT; Pym, BA | 1 |
| Lin, C; Zhang, TM | 1 |
| Chen, YN; Fan, GC; Xia, SX; Zhang, YP | 1 |
| Otter, GM; Ren, YF; Schmid, FA | 1 |
4 other study(ies) available for bimolane and Sarcoma 180
| Article | Year |
|---|---|
Effect of AT1727 on growth and metastasis of murine tumours.
Topics: Animals; Antineoplastic Agents; Drug Administration Schedule; Female; Leukemia L1210; Lung Neoplasms; Lymphoma; Male; Melanoma; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Piperazines; Razoxane; Sarcoma 180 | 1983 |
[The cytokinetic effects of bimolane (AT-1727) on S180 cells].
Topics: Animals; Antineoplastic Agents; Cell Cycle; DNA, Neoplasm; Mice; Piperazines; Razoxane; Sarcoma 180 | 1982 |
[Relationship between radiation sensitization and DNA damage by bimolane].
Topics: Animals; Antineoplastic Agents; Cross-Linking Reagents; DNA Damage; DNA, Neoplasm; Mice; Piperazines; Radiation-Sensitizing Agents; Razoxane; Sarcoma 180 | 1987 |
Further evaluation of bimolane and analogs as potential antitumor agents.
Topics: Animals; Drug Resistance; Female; Leukemia L1210; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Osteosarcoma; Piperazines; Razoxane; Sarcoma 180 | 1985 |